Jagpreet Chhatwal
Jagpreet Chhatwal
Harvard Medical School, Massachusetts General Hospital
Потвърден имейл адрес: mgh.harvard.edu - Начална страница
Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States
J Chhatwal, F Kanwal, MS Roberts, MA Dunn
Annals of internal medicine 162 (6), 397-406, 2015
Prevention of prescription opioid misuse and projected overdose deaths in the United States
Q Chen, MR Larochelle, DT Weaver, AP Lietz, PP Mueller, S Mercaldo, ...
JAMA network open 2 (2), e187621-e187621, 2019
Comparison of logistic regression and artificial neural network models in breast cancer risk estimation
T Ayer, J Chhatwal, O Alagoz, CE Kahn Jr, RW Woods, ES Burnside
Radiographics 30 (1), 13-22, 2010
Breast cancer risk estimation with artificial neural networks revisited: discrimination and calibration
T Ayer, O Alagoz, J Chhatwal, JW Shavlik, CE Kahn Jr, ES Burnside
Cancer 116 (14), 3310-3321, 2010
Ensemble forecasts of coronavirus disease 2019 (COVID-19) in the US
EL Ray, N Wattanachit, J Niemi, AH Kanji, K House, EY Cramer, J Bracher, ...
MedRXiv, 2020.08. 19.20177493, 2020
Prevention of hepatitis C by screening and treatment in US prisons
T He, K Li, MS Roberts, AC Spaulding, T Ayer, JJ Grefenstette, J Chhatwal
Annals of internal medicine 164 (2), 84-92, 2016
Economic burden of chronic lymphocytic leukemia in the era of oral targeted therapies in the United States
Q Chen, N Jain, T Ayer, WG Wierda, CR Flowers, SM O’Brien, MJ Keating, ...
Journal of Clinical Oncology 35 (2), 166, 2017
The changing burden of hepatitis C virus infection in the United States: model-based predictions
M Kabiri, AB Jazwinski, MS Roberts, AJ Schaefer, J Chhatwal
Annals of internal medicine 161 (3), 170-180, 2014
Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United States
EY Cramer, EL Ray, VK Lopez, J Bracher, A Brennen, ...
Proceedings of the National Academy of Sciences 119 (15), e2113561119, 2022
Hepatitis C disease burden in the United States in the era of oral direct‐acting antivirals
J Chhatwal, X Wang, T Ayer, M Kabiri, RT Chung, C Hur, JM Donohue, ...
Hepatology 64 (5), 1442-1450, 2016
Oral human papillomavirus infection: differences in prevalence between sexes and concordance with genital human papillomavirus infection, NHANES 2011 to 2014
K Sonawane, R Suk, EY Chiao, J Chhatwal, P Qiu, T Wilkin, AG Nyitray, ...
Annals of internal medicine 167 (10), 714-724, 2017
Optimal breast biopsy decision-making based on mammographic features and demographic factors
J Chhatwal, O Alagoz, ES Burnside
Operations research 58 (6), 1577-1591, 2010
Hepatocellular carcinoma detection: diagnostic performance of a simulated abbreviated MRI protocol combining diffusion-weighted and T1-weighted imaging at the delayed phase …
C Besa, S Lewis, PV Pandharipande, J Chhatwal, A Kamath, N Cooper, ...
Abdominal Radiology 42, 179-190, 2017
Direct-acting antiviral agents for patients with hepatitis C virus genotype 1 infection are cost-saving
J Chhatwal, T He, C Hur, MA Lopez-Olivo
Clinical Gastroenterology and Hepatology 15 (6), 827-837. e8, 2017
Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019–40: a modelling study
J Julien, T Ayer, ED Bethea, EB Tapper, J Chhatwal
The Lancet Public Health 5 (6), e316-e323, 2020
Probabilistic Computer Model Developed from Clinical Data in National Mammography Database Format to Classify Mammographic Findings1
ES Burnside, J Davis, J Chhatwal, O Alagoz, MJ Lindstrom, BM Geller, ...
Radiology 251 (3), 663-672, 2009
Long‐term clinical impact and cost‐effectiveness of obeticholic acid for the treatment of primary biliary cholangitis
S Samur, M Klebanoff, R Banken, DS Pratt, R Chapman, DA Ollendorf, ...
Hepatology 65 (3), 920-928, 2017
Hepatitis C: the beginning of the end—key elements for successful European and national strategies to eliminate HCV in Europe
GV Papatheodoridis, A Hatzakis, E Cholongitas, R Baptista‐Leite, ...
Journal of viral hepatitis 25, 6-17, 2018
Bariatric surgery for nonalcoholic steatohepatitis: a clinical and cost‐effectiveness analysis
MJ Klebanoff, KE Corey, J Chhatwal, LM Kaplan, RT Chung, C Hur
Hepatology 65 (4), 1156-1164, 2017
Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list
J Chhatwal, S Samur, B Kues, T Ayer, MS Roberts, F Kanwal, C Hur, ...
Hepatology 65 (3), 777-788, 2017
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20